This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Embolism Outcomes Pulmonary 
Med Page Today
JANUARY 1, 2024
(MedPage Today) -- Mortality rates were high among patients with high-risk pulmonary embolism (PE), with the worst outcomes in those with hemodynamic collapse, according to a retrospective analysis of the Pulmonary Embolism Response Team (PERT.
111 
Frontiers in Cardiovascular Medicine
JULY 24, 2024
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a severe and complex condition that evolves from unresolved pulmonary embolism, leading to fibrotic obstruction of pulmonary arteries, pulmonary hypertension, and potential right heart failure.
98 
Medical Xpress - Cardiology
OCTOBER 30, 2024
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT) for intermediate-risk pulmonary embolism (PE) show that LBMT is superior with respect to the hierarchically-tested aggregated outcome of all-cause (..)
52 
Circulation: Cardiovascular Interventions
JANUARY 24, 2024
BACKGROUND:Prior clinical trials have demonstrated the efficacy of ultrasound-facilitated catheter-directed thrombolysis (USCDT) for the treatment of acute intermediate-risk pulmonary embolism (PE) using reduced thrombolytic doses and shorter infusion durations.
75 
Frontiers in Cardiovascular Medicine
FEBRUARY 14, 2024
Background Pulmonary embolism is a condition of right cardiac dysfunction due to pulmonary circulation obstruction. Malignant tumor-induced pulmonary embolism, which has a poor therapeutic outcome and a significant impact on hemodynamics, is the cause of sudden death in patients with malignant tumors.
64 
ECG Cases
NOVEMBER 6, 2018
This Best Case Ever elucidates the practical challenges of working up pregnant patients in the ED with a suspicion of pulmonary embolism. Since this recording, the first ever multi-center prospective outcome study looking at the pulmonary embolism workup in pregnancy was published in the Annals of Internal Medicine.
52 
DAIC
MARCH 14, 2025
Some of the late-breaking topics that will be covered include transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE): Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation (..)
52 
Frontiers in Cardiovascular Medicine
MARCH 27, 2024
In this case report, we demonstrated that thrombus aspiration and in situ thrombolysis through the Guidezilla GEC are applicable to patients with PE in whom systemic thrombolysis is contraindicated, resulting in successful reperfusion and positive clinical outcomes.
64 
Frontiers in Cardiovascular Medicine
DECEMBER 20, 2023
Massive pulmonary embolism (MPE) carries significant 30-day mortality and is characterized by acute right ventricular failure, hypotension, and hypoxia, leading to cardiovascular collapse and cardiac arrest. Considerable heterogeneity in studies is a significant weakness of the available literature.
56 
Frontiers in Cardiovascular Medicine
JULY 1, 2024
Notably, acute massive pulmonary embolism (PE) with bilateral atrial thrombosis is an exceptional occurrence in CAPS. Acute pulmonary embolism (PE) is a common cardiovascular disease that progresses rapidly and has a high mortality rate. It primarily affects small vessels, seldom impacting large vessels.
52 
Circulation: Cardiovascular Interventions
JANUARY 20, 2025
BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).METHODS:This A total of 16 patients (12% of patients) experienced the primary composite outcome. days;P=0.046).
40 
Dr. S. Venkatesan MD
OCTOBER 15, 2024
A new Intelligent thrombo-suction catheter system , is being introduced for treatment of acute pulmonary embolism.This device regulates the force with which thrombus is sucked , with less injury and bleeding and better outcomes. They have become a Integral tool kit in peripheral arterial, venous and also pulmonary thrombosis.We
52 
JAMA Cardiology
NOVEMBER 21, 2023
This cohort study assesses outcomes in patients with pulmonary embolism using high-sensitivity vs conventional troponin I.
40 
DAIC
JANUARY 30, 2025
a powerful and advanced mechanical thrombectomy system for the removal of venous thrombus and the treatment of pulmonary embolism (PE), effectively completing Penumbras VTE platform. Penumbras continuous advancements provide a comprehensive portfolio for physicians to treat a wider range of patients and improve patient outcomes.
52 
The American Journal of Cardiology
OCTOBER 29, 2024
Publication date: Available online 28 October 2024 Source: The American Journal of Cardiology Author(s): Aryan Mehta, Mridul Bansal, Siddhant Passey, Saurabh Joshi, Carlos L Alviar, Jason N Katz, J Dawn Abbott, Saraschandra Vallabhajosyula
40 
The American Journal of Cardiology
JANUARY 1, 2025
Publication date: Available online 31 December 2024 Source: The American Journal of Cardiology Author(s): Aryan Mehta, Mridul Bansal, Abhishek Singh, Ritika Kompella, Anindita Chanda, Chirag Mehta, Christopher J Mullin, J Dawn Abbott, Saraschandra Vallabhajosyula
40 
American College of Cardiology
APRIL 16, 2024
What are the in-hospital and readmission outcomes in patients with intermediate-risk or high-risk pulmonary embolism (PE) treated with versus without catheter-based therapies (CBTs) in a large retrospective registry?
56 
Journal of Cardiovascular Electrophysiology
MARCH 6, 2024
This novel cryoballoon with adjustable size and low compliance successfully achieves pulmonary vein isolation to treat paroxysmal atrial fibrillation (PAF), providing more options for patients with PAF. Procedural outcomes were defined based on the 2017 HRS consensus statement. Follow-up was performed at 7 days, 3, 6, and 12 months.
40 
EMS 12-Lead
MARCH 30, 2024
The receiving staff suspects pulmonary embolism due to S1Q3T3 on the ECG and administers TPA. The patient did have massive pulmonary emboli, but he also had profound intraventricular and subarachnoid hemorrhages. The patient was ultimately discharged with a poor neurologic outcome. On ED arrival ROSC is achieved.
124 
Circulation: Cardiovascular Interventions
FEBRUARY 27, 2024
In this study, we assessed the clinical predictors and outcomes of advanced therapy compared with anticoagulation alone for the acute management of right heart thrombus.Methods:In this observational cohort study, we analyzed consecutive patients who were treated for right heart thrombus. The primary end point was 90-day all-cause mortality.
40 
Journal of the American Heart Association
NOVEMBER 28, 2023
Although the clinical outcomes and economic burdens of VTE have been well described, the impact of VTE on patients' health status has yet to be summarized. After screening and exclusion, 136 references were identified; 5 described PROM development, 20 focused on PROM validation, and 111 used PROMs in outcomes research.
Frontiers in Cardiovascular Medicine
JANUARY 29, 2025
BackgroundThe VenaTech Convertible Vena Cava Filter (VTCF) is a device designed for insertion into the inferior vena cava (IVC) to prevent life-threatening pulmonary embolism (PE). For younger or thrombophilic patients, careful evaluation of the filter's suitability and extended follow-up are crucial to optimize outcomes.
52 
Frontiers in Cardiovascular Medicine
JANUARY 15, 2024
In the light of increasing availability, the analyses of outcome-relevant predisposing characteristics are of growing importance. The primary outcome was defined as the survival of patients until they were discharged from the hospital, with a favourable neurological outcome [cerebral performance category (CPC) score of ≤2].
Journal of the American Heart Association
MARCH 8, 2024
A slowly maturing evidence base has suggested that cardiogenic shock teams may improve patient outcomes.
Heart BMJ
JULY 25, 2024
We aimed to assess the characteristics and outcomes of SCA according to cancer history. vs 46.8%, p<0.001) and had more respiratory causes (pulmonary embolism and hypoxaemia in 34.2% Still, in-hospital outcomes remain similar even in patients with known cancer. vs 10.8%, p<0.001). vs 29.8%, respectively, p=0.27).
Stroke Journal
JANUARY 30, 2025
Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA). Patients with any adverse vascular outcomes before the index ECG were excluded. The prevalences of all vascular outcomes are summarized in Table 1. p < 001).
Stroke Journal
FEBRUARY 1, 2024
Our primary study outcome was any stroke or major thrombotic event identified within 60 days of OHSS diagnosis in HCUP or during the index admission for OHSS in NIS. The low rate of outcome events after OHSS seen in each of our population-level analyses increases the reliability of these study results.
40 
Open Heart
NOVEMBER 28, 2023
Eligible were all aetiological studies evaluating risk of cardiovascular outcomes after exposure to common RTIs within any follow-up duration. to 10)), pulmonary embolism (24.6 This systematic review and meta-analysis aimed to estimate the causal effects of RTIs on occurrence of cardiovascular diseases in the general population.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
This study aims to investigate the incidence, complications, and outcomes of SAH patients who develop HIT.MethodsICD‐9‐CM and ICD‐10‐CM codes were used to query the National Inpatient Sample for patients with SAH between 2010 and 2019. Patients with SAH are an understudied population in terms of assessing incidence and impact of HIT.
40 
Stroke Journal
JANUARY 30, 2025
Introduction:Atrial fibrillation (AF) significantly elevates the risk of ischemic stroke and systemic embolism. Data on demographics, medical history, concurrent medications, and clinical outcomes were collected. Stroke, Volume 56, Issue Suppl_1 , Page A40-A40, February 1, 2025. Exclusions were malignancy and pregnancy/lactation.
40 
Dr. S. Venkatesan MD
JUNE 17, 2024
The usefulness of JVP in a cardiac emergency like acute pulmonary embolism may appear superfluous. But, the fact of the matter is, a persistently raised JVP with good waveform, without systemic hypotension, may not portend a bad outcome. Please go to the full-screen view and freeze the video to read the text.
40 
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
A prior published analysis of national trends after one year in mechanical thrombectomy use and outcomes for stroke before and after publication of the 2015 US guideline update showed improved functional outcomes and lower peri‐procedural mortality. Safety outcomes include in‐hospital medical complications and mortality.
40 
Circulation
NOVEMBER 11, 2023
Results:From 785 unique citations, we identified two randomized trials with relevant clinical outcome data; NOAH-AFNET 6 (2,536 participants) evaluated edoxaban and ARTESiA (4,012 participants) evaluated apixaban. We used random-effects models for meta-analysis and rated the quality of evidence using the GRADE framework.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Further research and attention to this area are crucial for improving patient outcomes and guiding clinical interventions in this challenging condition.MethodsICD‐10‐CM codes were used to query the National Inpatient Sample (NIS) for patients with AIS between 2010 and 2019.
40 
Dr. Smith's ECG Blog
NOVEMBER 25, 2017
Peak troponin, echocardiographic findings, and long term outcome are unknown. A new right bundle branch block in a sick patient with chest pain and/or shortness of breath is a worrisome finding concerning for LAD occlusion or significant pulmonary embolism. Learning Points: 1.
52 
DAIC
MAY 7, 2024
Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonary embolism (PE) treatment. Late-breaking results from the study, for which Sahil A.
122 
Dr. Smith's ECG Blog
JANUARY 9, 2023
CT angiogram chest: no aortic dissection or pulmonary embolism. Serial chest xrays: progressive bilateral pulmonary edema. Smith Major Learning Point: The worst risk factor for a bad outcome in OMI is young age because cardiologists cannot believe that a young person can have an OMI. No further troponins were measured.
52 
Circulation
MARCH 20, 2025
Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. This scientific statement summarizes disparities in diagnosis, treatment strategies, and outcomes related to pulmonary embolism, and reviews approaches to create equitable pulmonary embolism care and address the knowledge gaps in the literature.
70 
Dr. Smith's ECG Blog
NOVEMBER 12, 2020
and the patient was converted to veno-venous (V-V) ECMO due to persistent pulmonary insufficiency. However, in multiple studies, even in the absence of AMI, both acute and chronic myocardial injury (as diagnosed by any elevated cTn) are powerful markers of adverse outcomes in both the short and long term. 3–8 Shi et al.
Dr. Smith's ECG Blog
JANUARY 12, 2023
CT pulmonary angiogram was negative for pulmonary embolism. Learning Points It takes dedicated learning and observation of outcomes and serial ECGs to learn how to distinguish subtle OMI patterns from OMI mimics like the cases above. Second troponin T resulted at 1,318 ng/L. Chest x-ray was read as normal. Reocclusion!
52 Stroke Journal
FEBRUARY 1, 2024
Our study aimed to compare outcomes of patients diagnosed with CVT within 2 weeks of COVID infection compared to those without COVID-19.Methods:Adult All-cause mortality was the primary outcome. Stroke, Volume 55, Issue Suppl_1 , Page AWMP49-AWMP49, February 1, 2024. vs 13.6%; HR=1.51; 95% CI=1.04-2.20) 2.20) but not at three months.
40 Stroke Journal
FEBRUARY 1, 2024
Prolonged ICU LoS is reported to be associated with worse clinical outcomes, but factors associated with prolonged LoS after MT are not established.Methods:A retrospective analysis of 499 patients undergoing EVT at a single large comprehensive stroke center from January 2015 to May 2020 was performed. P<0.001). ASPECTS < 7 (6.9
40 
Dr. Smith's ECG Blog
APRIL 8, 2015
Cardiac Syncope ("True Syncope") Independent Predictors of Adverse Outcomes condensed from multiple studies 1. These premonitory symptoms were negative predictors of adverse outcomes in EGSYS. Aortic Dissection, Valvular (especially Aortic Stenosis), Tamponade. Abnormal ECG – looks for cardiac syncope. Syncope with Exertion (EGSYS) 7.
52
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content